Gopalan Sethuraman

5.3k total citations · 2 hit papers
61 papers, 3.8k citations indexed

About

Gopalan Sethuraman is a scholar working on Psychiatry and Mental health, Physiology and Clinical Psychology. According to data from OpenAlex, Gopalan Sethuraman has authored 61 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Psychiatry and Mental health, 26 papers in Physiology and 13 papers in Clinical Psychology. Recurrent topics in Gopalan Sethuraman's work include Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (14 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Gopalan Sethuraman is often cited by papers focused on Alzheimer's disease research and treatments (19 papers), Dementia and Cognitive Impairment Research (14 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Gopalan Sethuraman collaborates with scholars based in United States, United Kingdom and Japan. Gopalan Sethuraman's co-authors include Eric Siemers, Floyd R. Sallee, Paul Aisen, Richard C. Mohs, Martin R. Farlow, Rema Raman, Jennifer Leonard, David Neal Franz, Rachelle S. Doody and Gail Chuck and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and Neurology.

In The Last Decade

Gopalan Sethuraman

59 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

2013 903 citations Eric Siemers, Gopalan Sethuraman et al. profile →
The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease

2022 130 citations Reisa A. Sperling, Gopalan Sethuraman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gopalan Sethuraman United States	27	1.9k	1.0k	668	607	498	61	3.8k
Benedetta Nacmias Italy	39	2.2k 1.1×	1.3k 1.2×	1.7k 2.5×	359 0.6×	440 0.9×	212	5.3k
Hong Liu‐Seifert United States	25	1.7k 0.9×	1.5k 1.5×	411 0.6×	1.0k 1.7×	193 0.4×	53	3.6k
Thomas Leyhe Germany	33	1.7k 0.9×	1.1k 1.1×	642 1.0×	419 0.7×	139 0.3×	95	4.0k
M. Axel Wollmer Germany	25	1.3k 0.7×	351 0.3×	954 1.4×	291 0.5×	135 0.3×	56	2.9k
Xiaoyan Sun United States	33	2.4k 1.3×	623 0.6×	1.3k 2.0×	557 0.9×	92 0.2×	86	4.1k
Michael S. Rafii United States	33	1.7k 0.9×	1.3k 1.3×	979 1.5×	470 0.8×	104 0.2×	112	4.8k
Debby W. Tsuang United States	35	2.2k 1.1×	1.4k 1.4×	1.2k 1.9×	291 0.5×	276 0.6×	103	4.9k
Lutz Froelich Germany	19	1.9k 1.0×	1.4k 1.4×	777 1.2×	569 0.9×	76 0.2×	54	3.9k
Scott W. Andersen United States	21	1.1k 0.6×	1.8k 1.7×	348 0.5×	812 1.3×	239 0.5×	65	3.0k
Alberto Pupi Italy	39	1.9k 1.0×	1.5k 1.5×	872 1.3×	235 0.4×	147 0.3×	146	6.0k

Countries citing papers authored by Gopalan Sethuraman

Since Specialization

Citations

This map shows the geographic impact of Gopalan Sethuraman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gopalan Sethuraman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gopalan Sethuraman more than expected).

Fields of papers citing papers by Gopalan Sethuraman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gopalan Sethuraman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gopalan Sethuraman. The network helps show where Gopalan Sethuraman may publish in the future.

Co-authorship network of co-authors of Gopalan Sethuraman

This figure shows the co-authorship network connecting the top 25 collaborators of Gopalan Sethuraman. A scholar is included among the top collaborators of Gopalan Sethuraman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gopalan Sethuraman. Gopalan Sethuraman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siemers, Eric, Gopalan Sethuraman, Karen Sundell, et al.. (2025). INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease. The Journal of Prevention of Alzheimer s Disease. 12(1). 100005–100005. 4 indexed citations

Cline, Erika N., Karen Sundell, Elizabeth A. Johnson, et al.. (2025). Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease. The Journal of Prevention of Alzheimer s Disease. 12(4). 100082–100082. 2 indexed citations

Yu, Peng, Robert A. Dean, Stephen D. Hall, et al.. (2012). Enriching Amnestic Mild Cognitive Impairment Populations for Clinical Trials: Optimal Combination of Biomarkers to Predict Conversion to Dementia. Journal of Alzheimer s Disease. 32(2). 373–385. 27 indexed citations

Reaven, Gerald M., Jeffrey A. Lieberman, Gopalan Sethuraman, et al.. (2009). In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment. Journal of Psychiatric Research. 43(11). 997–1002. 15 indexed citations

Beasley, Charles M., Virginia K. Sutton, Cindy C. Taylor, et al.. (2006). Is Quality of Life Among Minimally Symptomatic Patients With Schizophrenia Better Following Withdrawal or Continuation of Antipsychotic Treatment?. Journal of Clinical Psychopharmacology. 26(1). 40–44. 12 indexed citations

Barzman, Drew H., et al.. (2005). Impulsive aggression with irritability and responsive to divalproex: A pediatric bipolar spectrum disorder phenotype?. Journal of Affective Disorders. 88(3). 279–285. 17 indexed citations

Gilbert, Donald L., Alok Bansal, Gopalan Sethuraman, et al.. (2004). Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome. Movement Disorders. 19(4). 416–425. 129 indexed citations

Chae, Jeong‐Ho, Ziad Nahas, Eric M. Wassermann, et al.. (2004). A Pilot Safety Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Tourette’s Syndrome. Cognitive and Behavioral Neurology. 17(2). 109–117. 60 indexed citations

Brehm, Bonnie J., et al.. (2003). Psychosocial Outcomes of a Pilot Multidisciplinary Program for Weight Management. American Journal of Health Behavior. 27(4). 348–354. 11 indexed citations

10.

Buell, Joseph F., Jennifer Trofe, Gopalan Sethuraman, et al.. (2003). Donors with central nervous system malignancies: are they truly safe?. Transplantation. 76(2). 340–343. 73 indexed citations

11.

Kowatch, Robert A., et al.. (2003). Combination pharmacotherapy in children and adolescents with bipolar disorder. Biological Psychiatry. 53(11). 978–984. 98 indexed citations

12.

Rourke, Kathleen, et al.. (2003). Effect of weight change on bone mass in female adolescents. Journal of the American Dietetic Association. 103(3). 369–372. 20 indexed citations

13.

Rohatgi, Nitin, et al.. (2002). Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low‐grade follicular lymphomas. American Journal of Hematology. 70(3). 181–185. 6 indexed citations

14.

Franz, David Neal, Alan S. Brody, Cristopher A. Meyer, et al.. (2001). Mutational and Radiographic Analysis of Pulmonary Disease Consistent with Lymphangioleiomyomatosis and Micronodular Pneumocyte Hyperplasia in Women with Tuberous Sclerosis. American Journal of Respiratory and Critical Care Medicine. 164(4). 661–668. 200 indexed citations

15.

Sallee, Floyd R., Gopalan Sethuraman, Lauren Sine, & Hong Liu. (2000). Yohimbine Challenge in Children With Anxiety Disorders. American Journal of Psychiatry. 157(8). 1236–1242. 24 indexed citations

16.

Sallee, Floyd R., Nandagopal Vrindavanam, Hong Liu, Gopalan Sethuraman, & Lauren Sine. (2000). Fenfluramine challenge in anxious children. Human Psychopharmacology Clinical and Experimental. 15(8). 619–629. 3 indexed citations

17.

Sallee, Floyd R., et al.. (1998). Clonidine Challenge in Childhood Anxiety Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 37(6). 655–662. 16 indexed citations

18.

Sallee, Floyd R., et al.. (1998). Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response. Biological Psychiatry. 44(7). 562–567. 18 indexed citations

19.

Lipinski, Joseph F., Floyd R. Sallee, Cherry W. Jackson, & Gopalan Sethuraman. (1997). Dopamine agonist treatment of tourette disorder in children: Results of an open‐label trial of pergolide. Movement Disorders. 12(3). 402–407. 68 indexed citations

20.

Sallee, Floyd R., et al.. (1995). Head Growth in Cocaine-Exposed Infants. Journal of Developmental & Behavioral Pediatrics. 16(2). 77???81–77???81. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact